Chronic Limb-Threatening Ischemia Treated With Intravascular Lithotripsy Observational Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCardiovascular and Interventional Radiological Society of Europe

About this trial

CALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemia (CLTI). The primary objective of CALCIO is to understand the effectiveness of IVL in promoting wound healing and preventing amputation. The secondary objectives of CALCIO are to evaluate the immediate effectiveness of the treatment in restoring vessel patency as well as its safety and impact on patients' quality of life.

Eligibility criteria

Qualifiers

Patient with chronic limb-threatening ischemia (Rutherford Category ≥4)

Femoropopliteal and/or crural calcified lesions visible on fluoroscopy;

Treatment with IVl using the Shockwave Medical IVL System.

Disqualifiers

< 18 years old;

Incapacity or refusal to give informed consent;

Ongoing pregnancy;

Endovascular procedure(s) on the treatment site within 4 weeks before the planned IVL treatment.

Trial design

Treatments tested in this trial

  • Shockwave Medical IVL System

Treatment groups

400 Participants
are divided into 1 treatment group

Locations

39
Austria
Krankenhaus der Barmherzigen Brüder7000, Eisenstadt Austria
Medizinische Universität Graz8036, Graz Austria
Krankenhaus Barmherzige Brüder Linz4020, Linz Austria
Klinik Florisdorf1210, Vienna Austria

Sponsors and collaborators

Cardiovascular and Interventional Radiological Society of Europe

Lead sponsor

Shockwave Medical, Inc.

Collaborator